EQT renews plans for $20bn Galderma IPO
Private Equity Wire
FEBRUARY 7, 2024
Stockholm-based global investment firm EQT is reconsidering a potential $20bn initial public offering for Galderma, a pharmaceutical company and former subsidiary of Nestlé, according to a report by the Financial Times citing people familiar with the matter.
Let's personalize your content